January 6, 2026 — A big change is afoot and the hype is cranking up. With the launch of Wegovy tablets by Novo Nordisk yesterday, we are seeing some very big expectations expressed for a new era in obesity care. The stock market has boosted the value of Novo stock by 15 percent since FDA approved these tablets. Yesterday […]
January 1, 2026 — The slate is clean. All is forgiven. We have a fresh new year ahead. So that has us thinking about the trends that are likely to define 2026 in obesity, nutrition, and health. Here are five that floated to the top of our mind. 1. Healthy Weight for Life We have said it before. Weight […]
December 23, 2025 — We strongly suspect that advanced oral obesity medicines may be a defining milestone for 2026. This is because they have the potential to fill an important gap in obesity therapy – the unmet need for therapies that people can persistently take to maintain control of this chronic disease. Late yesterday, FDA granted approval for the […]
